Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2013
10/15/2013CA2594770C 5-pyrrolidinylsulfonyl isatin derivatives
10/10/2013WO2013152206A1 Novel triazole compounds that modulate hsp90 activity
10/10/2013WO2013151982A1 Methods and compounds useful in treating pruritus, and methods for identifying such compounds
10/10/2013WO2013151923A1 Pyrimidinone carboxamides as inhibitors of endothelial lipase
10/10/2013WO2013151877A1 Pyrimidinedione carboxamide inhibitors of endothelial lipase
10/10/2013WO2013151597A2 (1,2,3-triazolyl) sulfonyl derivatives
10/10/2013WO2013151297A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
10/10/2013WO2013149976A1 Indole-pyrimidine derivatives and their therapeutic uses
10/10/2013WO2013149704A1 Cyclic amides as metap-2 inhibitors
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130267711 Tricyclic compound
10/10/2013US20130267546 Multifunctional Radical Quenchers and Their Uses
10/10/2013US20130267542 Histone deacetylases (hdacs) inhibitors
10/10/2013US20130267539 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
10/10/2013US20130267532 Cyclic amide compounds and their use in the treatment of disease
10/10/2013US20130267526 Heterocyclic compounds and their uses
10/10/2013US20130267525 Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
10/10/2013US20130267524 Heterocyclic compounds and their uses
10/10/2013US20130267493 Indole and indazole compounds that activate ampk
10/10/2013US20130267491 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them
10/09/2013EP2647634A1 Indole-pyrimidine derivatives and their therapeutic uses
10/09/2013EP2646433A1 Pyrimidine compound and use for pest control thereof
10/09/2013EP2646432A1 Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
10/09/2013EP2646431A1 A process for the preparation of pazopanib using novel intermediate
10/09/2013CN103347875A Indoles as respiratory syncytial virus antiviral agents
10/09/2013CN103347864A Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
10/09/2013CN103347857A Biscarbazole derivative and organic electroluminescent element using same
10/09/2013CN103342696A Substituted dihydropyrazolon for treating cardiovascular and haematological diseases
10/09/2013CN102050794B Quinoxalin derivative and organic LED (Light-Emitting Diode) containing same
10/09/2013CN101821254B Adrenergic compounds
10/08/2013US8552206 NF-κB inhibitors and uses thereof
10/08/2013US8552205 Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides
10/08/2013US8552186 Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors
10/08/2013US8552047 Hepatitis C virus inhibitors
10/08/2013US8552022 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
10/08/2013US8552016 Anti-cancer cyclopenta(g)quinazoline compounds
10/08/2013US8552015 Quinazolinone derivatives and their use as CB agonists
10/08/2013US8552004 Chemical compounds
10/08/2013US8552001 Sulfoxide derivatives for the treatment of tumors
10/08/2013US8551999 Heterocyclic compound and pharmaceutical composition thereof
10/08/2013US8551981 Furo[3,2-d]pyrimidine compounds
10/08/2013US8551965 Anti-viral pyrimidine nucleoside analogues
10/08/2013US8551625 Derivative with heteroaromatic ring, and light-emitting element, light-emitting device, lighting device, and electronic device using derivative with heteroaromatic ring
10/08/2013CA2634018C Pyrimidine derivatives
10/08/2013CA2570321C Inhibitors of iap
10/08/2013CA2531508C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/03/2013WO2013149147A1 Mesylate salt forms of a potent hcv inhibitor
10/03/2013WO2013148857A1 Triazole derivatives as hsp90 inhibitors
10/03/2013WO2013148603A1 Cinnoline derivatives as as btk inhibitors
10/03/2013WO2013147215A1 4-alkanoylamino-3-pyrazolone derivative
10/03/2013WO2013147205A1 Organic electroluminescent element and material for organic electroluminescent elements
10/03/2013WO2013147183A1 Triazinone compound and t-type calcium channel inhibitor
10/03/2013WO2013147117A1 Fused azole derivative
10/03/2013WO2013146963A1 Heterocyclic compound
10/03/2013WO2013146942A1 Novel compound, material for organic electroluminescence element, and organic electroluminescence element
10/03/2013WO2013144231A1 Herbicidal compounds
10/03/2013WO2013144187A1 5-aminopyrimidine derivatives and use thereof for combating undesired plant growth
10/03/2013WO2013144129A1 Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
10/03/2013WO2013143466A1 Substituted pyrimidine derivative as aurora kinase inhibitor
10/03/2013US20130261299 Pyridazinyl derivatives as smo inhibitors
10/03/2013US20130261297 1,2-bis-(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and intermediate for the synthesis of same
10/03/2013US20130261141 Novel heterocyclic compounds as pesticides
10/03/2013US20130261139 Use of a quinazoline compound in preparing a medicament against flaviviridae virus
10/03/2013US20130261134 Mesylate salt forms of a potent hcv inhibitor
10/03/2013US20130261128 Continuous arycyclic compound
10/03/2013US20130261123 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
10/03/2013US20130261119 Novel Anti-Cancer Agents
10/03/2013US20130261118 Compounds for alzheimer's disease
10/03/2013US20130261103 Pyridazinones, method of making, and method of use thereof
10/03/2013US20130261081 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
10/03/2013US20130261052 Inhibition of memapsin 1 cleavage in the treatment of diabetes
10/02/2013EP2644601A1 Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof
10/02/2013EP2644600A1 Heterocyclic aspartyl protease inhibitors
10/02/2013EP2643313A1 Quinazoline carboxamide azetidines
10/02/2013EP2643310A1 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as gpr 119 modulators
10/02/2013EP2643298A1 Substituted cyclopentyl - azines as casr- active compounds
10/02/2013EP2643297A1 Indole derivatives as modulators of s1p receptors
10/02/2013CN103339125A Pyrazole compounds as CRTH2 antagonists
10/02/2013CN103339111A Bicyclic acetyl-CoA carboxylase inhibitors
10/02/2013CN103337598A Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
10/02/2013CN103333162A 病毒聚合酶抑制剂 Viral polymerase inhibitors
10/02/2013CN103333160A 2,4,6-tri(1-H-tetrazole)-1,3,5-triazine compound and preparation method thereof
10/02/2013CN103333159A 2,4,6-tri(5-amino tetrazole)-1,3,5-triazine compound and preparation method thereof
10/02/2013CN103333158A N-phenylcarbazole derivative and application thereof to electrophosphorescent device
10/02/2013CN102186818B 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
10/02/2013CN101939316B Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
10/01/2013US8546792 Anthracene derivative, and light emitting element, light emitting device, and electronic device using the anthracene derivative
10/01/2013US8546586 Pyrazole-based cyanine dye containing quaternary ammonium cation
10/01/2013US8546569 Chemical compounds
10/01/2013US8546567 Method for producing 2-(2-aminopyrimidin-4-yl)-1H-indole-5-carboxylic acid derivatives
10/01/2013US8546505 Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials
10/01/2013US8546429 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013US8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
10/01/2013US8546398 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/01/2013US8546396 N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulators
10/01/2013US8546393 6-triazolopyridazine sulfanyl benzothiazole derivatives as MET inhibitors
10/01/2013US8546389 Viral polymerase inhibitors
10/01/2013US8546379 5HT2C receptor modulators
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 626